INCREASE IN SERUM ALKALINE PHOSPHATASE (S-ALP) IN CHRONIC MYELOCYTIC LEUKEMIA. SIGN OF DRUG-INDUCED CHOLESTASIS.HAST R.1978; ACTA MED. SCAND.; SUEDE; DA. 1978; VOL. 203; NO 1-2; PP. 93-94; BIBL. 5 REF.Article

SECONDARY HEMATOLOGICAL CHANGES MIMICKING THE PRELEUKEMIC SYNDROMEHAST R; BERAN M.1981; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1981; VOL. 209; NO 6; PP. 521-523; BIBL. 11 REF.Article

SIDEROBLASTIC ANEMIA AND DEVELOPMENT OF LEUKEMIAHAST R; REIZENSTEIN P.1981; BLUT; ISSN 0006-5242; DEU; DA. 1981; VOL. 42; NO 4; PP. 203-207; BIBL. 38 REF.Article

STUDIES ON HUMAN PRELEUKAEMIA. III: CHROMOSOMAL ABNORMALITIES IN AREGENERATIVE ANAEMIA WITH HYPERCELLULAR BONE MARROWGRANBERG OHMAN I; HAST R; VASS L et al.1980; HAEMOTOLOGICA (ROMA); ISSN 0390-6078; ITA; DA. 1980; VOL. 65; NO 4; PP. 421-436; ABS. ITA; BIBL. 37 REF.Article

THE IN VITRO PHAGOCYTIC FUNCTION OF NEUTROPHIL LEUKOCYTES IN PATIENTS WITH SEVERE CANDIDA-INDUCED DENTURE STOMATITIS.BERGENDAL TA; HAST R; SLOTTE M et al.1977; SCAND. J. DENT. RES.; DENM.; DA. 1977; VOL. 85; NO 7; PP. 610-612; BIBL. 11 REF.Article

Therapeutic aspects of myelodysplastic syndrome in chronic phaseHAST, R; HELLSTROM, E.Leukemia research. 1992, Vol 16, Num 1, pp 95-100, issn 0145-2126Article

INCREASED ARSENIC CONCENTRATION IN THE LONE MARROW IN CHRONIC RENAL FAILURE: A CONTRIBUTOR TO ANEMIA!PERSHAGEN G; HAST R; LINS CE et al.1982; NEPHRON; ISSN 0028-2766; CHE; DA. 1982; VOL. 30; NO 3; PP. 250-252; BIBL. 14 REF.Article

Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cellsROBAK, T; HAST, R; GOLDMAN, J. M et al.Experimental hematology. 1986, Vol 14, Num 3, pp 197-201, issn 0301-472XArticle

Comparison of acute myeloid leukemia occurring de novo or preceded by a myelodysplastic stage : differences in cellular DNA contentWIDELL, S; AUER, G; HAST, R et al.American journal of hematology. 1993, Vol 42, Num 3, pp 293-298, issn 0361-8609Article

Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromesHAST, R; NILSSON, I; WIDELL, S et al.Leukemia research. 1989, Vol 13, Num 2, pp 173-178, issn 0145-2126Article

Abnormal erythrocyte survival in patients with myotonic dystrophySYDOW, O; STIBLER, H; HAST, R et al.Acta neurologica scandinavica. 1985, Vol 72, Num 5, pp 522-524, issn 0001-6314Article

Bone marrow investigation in patients with lichen planusNORDLIND, K; LAGERHOLM, B; HAST, R et al.Dermatologica. 1983, Vol 173, Num 1, pp 13-15, issn 0011-9075Article

Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemiaBERNELL, P; ARVIDSSON, I; JACOBSSON, B et al.British journal of haematology. 1996, Vol 95, Num 4, pp 666-672, issn 0007-1048Article

Deletion of chromosome 2(p13) is a nonrandomly occurring karyotypic abnormality in myelodysplastic syndromeBERNELL, P; HAST, R; BRÖNDUM-NIELSEN, K et al.Cancer genetics and cytogenetics. 1992, Vol 59, Num 1, pp 97-98, issn 0165-4608Article

PERIPHERAL NEUROPATHY IN PATIENTS WITH BENIGN MONOCLONAL GAMMOPATHY: A PILOT STUDYNORING L; OSBY E; HAST R et al.1982; JOURNAL OF NEUROLOGY; ISSN 506702; DEU; DA. 1982; VOL. 228; NO 3; PP. 185-194; BIBL. 27 REF.Article

CELL-MEDIATED IMMUNITY IN HUMAN ACUTE MYELOBLASTIC LEUKEMIA: LYMPHOCYTE STIMULATION BY AUTOLOGOUS LEUKEMIC AND NONLEUKEMIC MYOBLASTSPAULI C; VANKY F; HAST R et al.1978; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1978; VOL. 5; NO 1; PP. 1-10; BIBL. 1 P.Article

Prediction of response to treatment with human recombinant erythropoietin in myelodysplastic syndromesSTENKE, L; WALLVIK, J; CELSING, F et al.Leukemia. 1993, Vol 7, Num 9, pp 1324-1327, issn 0887-6924Article

Differences in cell lineage involvement between MDS-AML and de novo AML studied by fluorescence in situ hybridization in combination with morphologyBERNELL, P; ARVIDSSON, I; HAST, R et al.European journal of haematology. 1997, Vol 58, Num 4, pp 241-245, issn 0902-4441Article

Increase of serum interleukin-2 and regression of myeloma after rhGM-CSF treatment of drug induced bone marrow aplasiaBERNELL, P; PISA, P; HAST, R et al.Hematological oncology. 1991, Vol 9, Num 3, pp 129-135, issn 0278-0232Article

Etoposide, doxorubicin, cyclophosphamide and high-dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myelomaOHRLIN, M; BJÖRKHOLM, M; GRUBER, A et al.European journal of haematology. 1993, Vol 51, Num 1, pp 45-49, issn 0902-4441Article

Natural interferon-α in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III : a randomized study from the Myeloma Group of central SwedenÖSTERBORG, A; BJÖRKHOLM, M; JOHANSSON, B et al.Blood. 1993, Vol 81, Num 6, pp 1428-1434, issn 0006-4971Article

Dilution and hemolysis causing anaemia after artificial heart implantationSTENKE, L; HAST, R; OSBY, E et al.Blut. 1987, Vol 54, Num 2, pp 127-128, issn 0006-5242Article

Difference between young and old patients in characteristics of leukemic cells: older patients have cells growing excessively in vitro, with low antigenicity despite high HLA-DR antigensGIANNOULIS, N; OGIER, C; HAST, R et al.American journal of hematology. 1984, Vol 16, Num 2, pp 113-121, issn 0361-8609Article

Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and feverENGERVALL, P; GÜNTHER, G; LJUNGMAN, P et al.Scandinavian journal of infectious diseases. 1996, Vol 28, Num 3, pp 297-303, issn 0036-5548Article

Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patientsENGERVALL, P; GÜNTHER, G; LJUNGMAN, P et al.Journal of chemotherapy. 1996, Vol 8, Num 5, pp 382-386, issn 1120-009XArticle